Enter access code to continue
Institutional-grade alpha from insurance claims data. Quantitative execution on S&P 500 pharma options, backtested across 11+ years.
A two-tier leveraged options strategy trading S&P 500 pharma constituents, powered by proprietary alternative data from insurance claims volume.
Insurance claims volume aggregated from proprietary sources
Real-time data processing and signal computation
Golden & secondary signal classification with confidence scoring
Automated options execution with risk management overlay
V5 Full strategy performance across 11+ years of historical data. All numbers from verified backtests on S&P 500 pharma constituents.
| Configuration | CAGR | Max DD | Win Rate | Trades |
|---|---|---|---|---|
| V4.3 Base (1-pos, flat 1% stop) | 548% | 35.4% | 44.0% | 405 |
| +Multi-Position (3) | 520% | 24.0% | 43.4% | 784 |
| +Vol-Adjusted Stops | 517% | 32.7% | 45.1% | 405 |
| +Scale-In (3 tranches) | 704% | 32.5% | 47.4% | 405 |
| +Re-Entry (max 2) | 730% | 30.9% | 50.5% | 405 |
| V5 FULL (all features) | 690% | 20.2% | 51.6% | 784 |
Multi-layered risk controls designed for institutional-grade capital preservation.
Dynamic stop-loss levels using 20-day lookback with 0.6x multiplier, bounded to 0.5%–2.0% range. Adapts to current market conditions in real-time.
Automatic leverage reduction when portfolio drawdown exceeds threshold. Prevents catastrophic losses during extreme market events.
Up to 3 concurrent positions spread across different pharma constituents, reducing single-name concentration risk.
Structured re-entry after stop-outs with maximum 2 attempts and 30-minute cooldown periods to avoid whipsaw losses.
Enterprise-grade technology stack built for reliability, speed, and institutional compliance.
Signal-to-order latency
System uptime (trailing 12mo)
Automated monitoring & alerts
Compliance-ready infrastructure
Schedule a walkthrough with our team to see live strategy performance, risk analytics, and platform capabilities.